Improved efficacy of mitoxantrone in patients with castration-resistant prostate cancer after vaccination with GM-CSF-transduced allogeneic prostate cancer cells

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
JournalOncoImmunology
Volume5
Issue number4
DOIs
Publication statusPublished - 2016

Cite this

@article{5268cb94731549d7995abf9ec5888ad4,
title = "Improved efficacy of mitoxantrone in patients with castration-resistant prostate cancer after vaccination with GM-CSF-transduced allogeneic prostate cancer cells",
keywords = "Cancer vaccines, chemotherapy, docetaxel, GVAX, immunotherapy, mitoxantrone, prostate cancer",
author = "{van Dodewaard-de Jong}, {Joyce M.} and Santegoets, {Saskia J. A. M.} and {van de Ven}, {Peter M.} and Jurjen Versluis and Verheul, {Henk M. W.} and {de Gruijl}, {Tanja D.} and Gerritsen, {Winald R.} and {van den Eertwegh}, {Alfons J. M.}",
year = "2016",
doi = "10.1080/2162402X.2015.1105431",
language = "English",
volume = "5",
journal = "OncoImmunology",
issn = "2162-4011",
publisher = "Landes Bioscience",
number = "4",

}

TY - JOUR

T1 - Improved efficacy of mitoxantrone in patients with castration-resistant prostate cancer after vaccination with GM-CSF-transduced allogeneic prostate cancer cells

AU - van Dodewaard-de Jong, Joyce M.

AU - Santegoets, Saskia J. A. M.

AU - van de Ven, Peter M.

AU - Versluis, Jurjen

AU - Verheul, Henk M. W.

AU - de Gruijl, Tanja D.

AU - Gerritsen, Winald R.

AU - van den Eertwegh, Alfons J. M.

PY - 2016

Y1 - 2016

KW - Cancer vaccines

KW - chemotherapy

KW - docetaxel

KW - GVAX

KW - immunotherapy

KW - mitoxantrone

KW - prostate cancer

U2 - 10.1080/2162402X.2015.1105431

DO - 10.1080/2162402X.2015.1105431

M3 - Article

VL - 5

JO - OncoImmunology

JF - OncoImmunology

SN - 2162-4011

IS - 4

ER -